Real-life effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: An Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter cohort study

被引：0
|
作者：
Baek, J. E. [1 ]
Kim, E. S. [2 ]
Kim, K. O. [3 ]
Jo, H. H. [4 ]
Hwang, S. W. [1 ,5 ]
Park, S. H. [1 ,5 ]
Jang, B. I. [3 ]
Kim, E. Y. [4 ]
Yang, S. K. [1 ,5 ]
Kim, S. K. [2 ]
Ye, B. D. [1 ,5 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[2] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea
[3] Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea
[4] Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Inflammatory Bowel Dis Ctr, Seoul, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P374
引用
收藏
页码：I780 / I781
页数：2
相关论文
共 50 条
  • [1] P0876 One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: An Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicentre real-world cohort study
    Baek, J. E.
    Kim, M. K.
    Kim, E. S.
    Kim, K. O.
    Jo, H. H.
    Hwang, S. W.
    Park, S. H.
    Jang, B., I
    Kim, E. Y.
    Yang, S. K.
    Kim, S. K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1666 - I1667
  • [2] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
    Shin, Seung Hwan
    Oh, Kyunghwan
    Hong, Sung Noh
    Lee, Jungbok
    Oh, Shin Ju
    Kim, Eun Soo
    Na, Soo-Young
    Kang, Sang-Bum
    Koh, Seong-Joon
    Bang, Ki Bae
    Jung, Sung-Ae
    Jung, Sung Hoon
    Kim, Kyeong Ok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Choi, Chang Hwan
    Ye, Byong Duk
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [3] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
    Shin, Seung Hwan
    Oh, Kyunghwan
    Hong, Sung Noh
    Lee, Jungbok
    Oh, Shin Ju
    Kim, Eun Soo
    Na, Soo-Young
    Kang, Sang-Bum
    Koh, Seong-Joon
    Bang, Ki Bae
    Jung, Sung-Ae
    Jung, Sung Hoon
    Kim, Kyeong Ok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Choi, Chang Hwan
    Ye, Byong Duk
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [4] Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: A KASID multicenter cohort study
    Oh, K.
    Hong, S. N.
    Kim, E. S.
    Na, S. Y.
    Kang, S. B.
    Koh, S. J.
    Bang, K. B.
    Jung, S. A.
    Kim, K. O.
    Choi, C. H.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S359 - S361
  • [5] Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
    Tursi, Antonio
    Mocci, Giammarco
    Scaldaferri, Franco
    Napolitano, Daniele
    Maresca, Rossella
    Pugliese, Daniela
    Semprucci, Gianluca
    Savarino, Edoardo
    Cuomo, Antonio
    Donnarumma, Laura
    Bodini, Giorgia
    Pasta, Andrea
    Maconi, Giovanni
    Cataletti, Giovanni
    Pranzo, Giuseppe
    Rodino, Stefano
    Sebkova, Ladislava
    Costa, Francesco
    Ferronato, Antonio
    Gaiani, Federica
    Marzo, Manuela
    Luppino, Ileana
    Fabiano, Giulia
    Paese, Pietro
    Elisei, Walter
    Monterubbianesi, Rita
    Faggiani, Roberto
    Grossi, Laurino
    Serio, Mariaelena
    Scarcelli, Antonella
    Lorenzetti, Roberto
    Allegretta, Leonardo
    Chiri, Stefania
    Grasso, Giuseppina
    Antonelli, Elisabetta
    Bassotti, Gabrio
    Spagnuolo, Rocco
    Luzza, Francesco
    Fanigliulo, Libera
    Rocco, Giulia
    Sacchi, Carlotta
    Zampaletta, Costantino
    Rocchi, Chiara
    Bolognini, Laura
    Bendia, Emanuele
    Bianco, Maria Antonia
    Capone, Pietro
    Meucci, Costantino
    Colucci, Raffaele
    Tonti, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (1-2) : 101 - 109
  • [6] Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study
    Mocci, G.
    Scaldaferri, F.
    Pugliese, D.
    Savarino, E.
    Bodini, G.
    Cuomo, A.
    Donnarumma, L.
    Maconi, G.
    Cataletti, G.
    Rodino, S.
    Sebkova, L.
    Ferronato, A.
    Gaiani, F.
    Marzo, M.
    Luppino, I.
    Paese, P.
    Elisei, W.
    Monterubbianesi, R.
    Faggiani, R.
    Napolitano, D.
    Grossi, L.
    Serio, M.
    Scarcelli, A.
    Lorenzetti, R.
    Allegretta, L.
    Rocco, G.
    Zampaletta, C.
    Bolognini, L.
    Meucci, C.
    Colucci, R.
    Tonti, P.
    Della Valle, N.
    Piga, R.
    Forti, G.
    Onidi, F. M.
    Satta, P. Usai
    Picchio, M.
    Papa, A.
    Tursi, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1065 - I1066
  • [7] Effectiveness of upadacitinib in patients with Ulcerative Colitis: a real-life, multicenter, Italian report
    Teani, I.
    Bevilacqua, N.
    Gabbiadini, R.
    Bezzio, C.
    Ferronato, A.
    Saibeni, S.
    Armuzzi, A.
    Comberlato, M.
    Desideri, F.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1045 - I1046
  • [8] EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: A REAL-LIFE, MULTICENTER, ITALIAN REPORT
    Teani, I
    Bevilacqua, N.
    Gabbiadini, R.
    Bezzio, C.
    Ferronato, A.
    Saibeni, S.
    Armuzzi, A.
    Comberlato, M.
    Desideri, F.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S244 - S245
  • [9] Effectiveness and safety of biosimilar infliximab (remsima) in a real-life setting in 84 patients with Crohn's disease and ulcerative colitis
    Gheorghe, C.
    Svoboda, P.
    Dimitriu, A.
    Mateescu, B.
    Kotzev, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S316 - S317
  • [10] SAFETY AND EFFECTIVENESS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS: A BRAZILIAN MULTICENTER REAL-WORLD STUDY
    Parra, Rogerio S.
    Azevedo, Matheus
    Chebli, Liliana A.
    Zabot, Gilmara P.
    Cassol, Ornella S.
    Lubini, Marcio
    Alves, Antonio, Jr.
    Teixeira, Fabio V.
    Kotze, Paulo G.
    Moraes, Antonio Carlos
    Santana, Genoile O.
    Froes, Renata
    Gasparetti, Newton, Jr.
    Feres, Omar
    Chebli, Julio
    GASTROENTEROLOGY, 2023, 164 (06) : S1004 - S1004
12345